-
July 13: The Week in Cancer NewsAn opinion piece discusses how the stigma surrounding opioids affects cancer patients, and a study provides data on treating melanoma patients with brain metastases.
by Kate Yandell
-
July 6: The Week in Cancer NewsStudies explore what type of cervical cancer screening is most effective and whether patients with autoimmune diseases can take immunotherapy.
by Kate Yandell
-
June 29: The Week in Cancer NewsStudies explore occupational hazards that could increase cancer risk, and the U.S. Food and Drug Administration approves a new combination therapy for melanoma.
by Kate Yandell
-
June 22: The Week in Cancer NewsExperts debate direct-to-consumer genetic testing and studies shed light on breast reconstruction complications.
by Kate Yandell
-
AACR Annual Meeting 2018A roundup of news from the American Association for Cancer Research Annual Meeting 2018.
-
Making Sense of Cancer ProgressCancer Today editor Kevin McLaughlin contemplates what it means to report on cancer research advances when so many continue to die of the disease.
by Kevin McLaughlin
-
A Book Club for Cancer Survivors and CaregiversShare your experiences as we discuss “A Cure Within” in a Cancer Today Facebook group.
by Marci A. Landsmann
-
Welcome to Our New WebsiteAn updated site and a new digital editor means better and faster cancer coverage for our readers.
by Cancer Today Staff
-
Integrative Strategies for Facing Cancer
Brain tumor survivor uses her experiences to help others.
by Jeannine Walston
Challenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
